Stephen Manzano is SVP, General Counsel of Amneal Pharmaceuticals, Inc.. Currently has a direct ownership of 10,694 shares of AMRX, which is worth approximately $89,722. The most recent transaction as insider was on Feb 27, 2021, when has been sold 5,796 shares (Class A Common Stock) at a price of $5.39 per share, resulting in proceeds of $31,240. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 10.7K
0% 3M change
0% 12M change
Total Value Held $89,722

Stephen Manzano Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 27 2021
SELL
Payment of exercise price or tax liability
$31,240 $5.39 p/Share
5,796 Reduced 35.15%
10,694 Class A Common Stock
Feb 27 2021
BUY
Exercise of conversion of derivative security
-
16,490 Added 50.0%
16,490 Class A Common Stock
SM

Stephen Manzano

SVP, General Counsel
Bridgewater, NJ

Track Institutional and Insider Activities on AMRX

Follow Amneal Pharmaceuticals, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AMRX shares.

Notify only if

Insider Trading

Get notified when an Amneal Pharmaceuticals, Inc. insider buys or sells AMRX shares.

Notify only if

News

Receive news related to Amneal Pharmaceuticals, Inc.

Track Activities on AMRX